About Us Faculty and Staff Education Research Clinical Services



Neuro-ophthalmology Faculty

Warren L. Felton, III, M.D.

 

Adult Neurology Faculty

Child Neurology Faculty

Neuroscience Research Faculty

Warren L. Felton, III, M.D.

Chairman, Division of Neuro-ophthalmology

Professor, Neurology

Associate Professor, Ophthalmology

Education
M.D. University of Oklahoma, College of Medicine, Oklahoma City, Oklahoma, 1980

B.A. University of Oklahoma, Norman, Oklahoma, 1973

Postdoctoral Training

Fellow, Neuro-ophthalmology, Virginia Commonwealth University, Medical College of Virginia campus, 1984-1985

Chief Resident, Neurology, Virginia Commonwealth University, Medical College of Virginia campus, 1983-1984

Resident, Neurology, Virginia Commonwealth University, Medical College of Virginia campus, 1981-1984

Awards

Outstanding Teacher Award, Neurology Residency, Virginia Commonwealth University, 2005

Instructor of the Year, Virginia Commonwealth University Department of Ophthalmology, 2003

African American Antiplatelet Stroke Prevention Study Outstanding Recruitment Award, 2000

Instructor of the Year, Virginia Commonwealth University Department of Ophthalmology, 1999

Outstanding Teacher Award, Neurology Residency, Virginia Commonwealth University, 1994

Current External Grants and Clinical Trials

Principal Investigator, National Institute of Neurologic Disease and Stroke, National Institutes of Health.  Warfarin versus Aspirin Reduced Cardiac Ejection Fraction study.

Principal Investigator, Stroke and Multiple Sclerosis clinical trials sponsored by industry

Recent Publications

CHAMPS Study Group. MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology 59: 998-1005, 2002

CHAMPS Study group. Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo group. Multiple sclerosis, 8, 405-409, 2002

CHAMPS Study Group. Baseline MRI characteristics of patients at high risk for multiple sclerosis: results of the CHAMPS trial. Multiple sclerosis 8, 330-338, 2002.

    

CHAMPS Study Group. Interferon B-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol, 132: 463-471, 2001 (writing committee).

Sugarman HJ, Felton III WL, Sismanis A, Saggi BH, Doty JM, Marmarou A, Makhoul RG. Continuous negative abdominal pressure device to treat pseudotumor cerebri. Inter J Obesity 25, 486-490, 2001.

Clinical Specialization

Neuro-ophthalmology, Stroke, Multiple Sclerosis

privacy statement
Contact Us
Date Last Modified: March 10, 2008